data + articles · 9 listed
newest 2025spec sheet10 rows
2C-I is a widely encountered 2C-series psychedelic phenethylamine bearing an iodine substituent at the 4-position. It acts principally as a 5-HT2A receptor agonist and reliably induces the 5-HT2A-mediated head-twitch response in mice, a behavioral proxy for hallucinogenic activity that is fully blocked by the selective antagonist M100907. Its scaffold is of particular pharmacological interest because N-benzylation to form 25I-NBOMe increases 5-HT2A affinity and in vivo potency by more than an order of magnitude, yielding a far more dangerous derivative that is sometimes mis-sold as 2C-I. 2C-I itself is characterized by bright, colorful visuals with a moderate stimulating quality, is metabolized largely via CYP2D6, and produces only limited monoamine oxidase inhibition. It is detectable in the urine of users among panels of 2C designer drugs.
- Classic 5-HT2A serotonergic psychedelic
- Bright, colorful visuals
- Mild stimulating quality
- 5-HT2A agonist and scaffold of superpotent 25I-NBOMe
- Nausea and vasoconstriction
- Stimulating body load
- Frequently misrepresented as dangerous NBOMe compounds
- Anxiety at higher amounts
Mechanism
2C-I is 2,5-dimethoxyphenethylamine with an iodine substituent at the 4-position; it acts as an at the receptor, the receptor central to the psychedelic state, with secondary activity at 5-HT2C and other serotonin sites. Its potency sits in the middle of the 2C range, and it carries a mild stimulant edge.
receptor fingerprint
receptoragonist
5-HT2C receptoragonist
Safetyrisks and cautions, not medical advice
2C-I is reasonably potent and easy to misjudge, bringing nausea, vasoconstriction, anxiety, and a stimulating body load at higher exposure. A major real-world danger is that blotter or powder sold as 2C-I may actually be a 25I-NBOMe compound, which is far more potent and has caused deaths; the two are not interchangeable. Combining it with MAOIs or other serotonergic drugs risks serotonin toxicity, and people with cardiovascular problems or a psychosis history should avoid it. Not medical advice.
Subjective profileweighing the evidence above
The pharmacology here is not the problem; identity is. What gets sold under the name has repeatedly turned out to be 25I-NBOMe instead, which is far more potent and has killed people, and the two are not interchangeable at any amount. Anyone with cardiovascular problems or a psychosis history should stay away, and it should never meet an MAOI.
Resources
This entry is here for reference.
Research
- 2008first citedLiquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determinat…
- 2025most recentThe role of mitochondrial dysfunction and calcium dysregulation in 2C-I and 25I-NBOMe-induced n…
- 1.2C or not 2C: phenethylamine designer drug review
- 2.The role of mitochondrial dysfunction and calcium dysregulation in 2C-I and 25I-NBOMe-induced neurotoxicity
- 3.Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs).
- 4.Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response.
- 5.Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats.
- 6.Investigation of the 2,5-Dimethoxy Motif in Phenethylamine Serotonin 2A Receptor Agonists.
- 7.Interactions of phenethylamine-derived psychoactive substances of the 2C-series with human monoamine oxidases.
- 8.Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers.
- 9.Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.
9 listed here; entry last updated July 2026
Reviews
My notesprivate to this device
FAQ
How does 2C-I work?
Mainly through agonism at the 5-HT2A serotonin receptor, like the other 2C psychedelics.
Why is the NBOMe confusion dangerous?
Material sold as 2C-I is sometimes actually 25I-NBOMe, which is vastly more potent and has caused fatalities; they are not interchangeable.
What should not be mixed with it?
MAOIs and other strongly serotonergic drugs, because of serotonin toxicity risk.
Adverse effects
- Nausea and vasoconstriction
- Stimulating body load
- Frequently misrepresented as dangerous NBOMe compounds
- Anxiety at higher amounts